Brief presence of varicella-zoster viral DNA in mononuclear cells during relapses of multiple sclerosis

Archives of Neurology

Volumn 61, Issue 4, 2004, Pages 529-532

  Ordoñez, Graciela ^a   Pineda, Benjamin ^a   Garcia Navarrete, Roberto ^a   Sotelo, Julio ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; VIRUS DNA; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MEXICO; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; REMISSION; RISK FACTOR; VARICELLA ZOSTER VIRUS; VIRUS ACTIVATION; BLOOD; CHICKENPOX; GENETICS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IMMUNOLOGY; MIDDLE AGED; VIROLOGY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHICKENPOX; DNA, VIRAL; FEMALE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYMERASE CHAIN REACTION; RISK FACTORS; VIRAL ENVELOPE PROTEINS;

EID: 2342482423     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.4.529     Document Type: Article

References (23)

1. Bachmann S, Kesselring J. Multiple sclerosis and infectious childhood diseases. Neuroepidemiology. 1998;17:154-160.
2. Bergstrom T. Several options for antiviral treatment trials in multiple sclerosis-but which targets should be selected? Expert Opin Pharmacother. 2000;1:1087-1090.
3. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol. 1996;2:249-258.
4. Alvarez R, Cour I, Kanaan A, et al. Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction (PCR) [in Spanish]. Enferm Infecc Microbiol Clin. 2000;18:223-228.
5. Ross RT. The varicella-zoster virus and multiple sclerosis. J Clin Epidemiol. 1998;51:533-535.
6. Marrie RA, Wolfson C. Multiple sclerosis and varicella zoster virus infection: a review. Epidemiol Infect 2001;127:315-325.
7. Gonzalez O, Sotelo J. Is the frequency of multiple sclerosis increasing in Mexico? J Neurol Neurosurg Psychiatry. 1995;59:528-530.
8. Tarrats R, Ordoñez G, Rios C, Sotelo J. Varicella, ephemeral breastfeeding and eczema as risk factors for multiple sclerosis in Mexicans. Acta Neurol Scand. 2002;105:88-94.
9. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000;343:1430-1438.
10. Sotelo J. Multiple viral pathogenicity. Perspect Biol Med. 1996;39:507-513.
11. Cohrs RJ, Randall J, Smith J, et al. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol. 2000;74:11464-11471.
12. Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Rentier B, Pierard GE. Immunohistochemical identification of varicella-zoster virus gene 63-encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use. J Med Virol. 1995;47:342-347.
13. Sadzot-Delvaux C, Kinchington PR, Debrus S, Rentier B, Arvin AM. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J Immunol. 1997;159:2802-2806.
14. Cohen JI, Straus SE. Varicella-zoster virus and its replication. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:2707-2730.
15. Heineman TC, Hall SL. Role of the varicella-zoster virus gB cytoplasmic domain in gB transport and viral egress. J Virol. 2002;76:591-599.
16. Gilden DH, Kleinschmidt-Demasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342:635-645.
17. Kleinschmidt-DeMasters BK, DeBiasi RL, Tyler KL. Polymerase chain reaction as a diagnostic adjunct in herpesvirus infections of the nervous system. Brain Pathol. 2001;11:452-464.
18. Jacobs JJ, Folkers E, Vreeswijk J. Detection of varicella-zoster virus and herpes simplex virus by the polymerase chain reaction with degenerate primers. J Virol Methods. 1999;83:155-167.
19. Longfield JN, Winn RE, Gibson RL, Vern Juchau S, Hoffman PV. Varicella outbreaks in army recruits from Puerto Rico. Arch Intern Med. 1990;150:970-973.
20. Weller TH. Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus: first of two parts. N Engl J Med. 1983;309:1362-1368.
21. Weller TH. Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus: second of two parts. N Engl J Med. 1983;309:1434-1440.
22. Lycke J, Svennerholm B, Hjelmquist E, et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. J Neurol. 1996;243:214-224.
23. Ross RT, Nicolle LE, Cheang M. The varicella zoster virus: a pilot trial of a potential therapeutic agent in multiple sclerosis. J Clin Epidemiol. 1997;50:63-68.